Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses - PubMed (original) (raw)
. 2009 Dec;12(12):1567-76.
doi: 10.1038/nn.2433.
Affiliations
- PMID: 19935655
- DOI: 10.1038/nn.2433
Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses
Efrat Abramov et al. Nat Neurosci. 2009 Dec.
Abstract
Accumulation of cerebral amyloid-beta peptide (Abeta) is essential for developing synaptic and cognitive deficits in Alzheimer's disease. However, the physiological functions of Abeta, as well as the primary mechanisms that initiate early Abeta-mediated synaptic dysfunctions, remain largely unknown. Here we examine the acute effects of endogenously released Abeta peptides on synaptic transfer at single presynaptic terminals and synaptic connections in rodent hippocampal cultures and slices. Increasing extracellular Abeta by inhibiting its degradation enhanced release probability, boosting ongoing activity in the hippocampal network. Presynaptic enhancement mediated by Abeta was found to depend on the history of synaptic activation, with lower impact at higher firing rates. Notably, both elevation and reduction in Abeta levels attenuated short-term synaptic facilitation during bursts in excitatory synaptic connections. These observations suggest that endogenous Abeta peptides have a crucial role in activity-dependent regulation of synaptic vesicle release and might point to the primary pathological events that lead to compensatory synapse loss in Alzheimer's disease.
Similar articles
- Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
Wang Z, Jackson RJ, Hong W, Taylor WM, Corbett GT, Moreno A, Liu W, Li S, Frosch MP, Slutsky I, Young-Pearse TL, Spires-Jones TL, Walsh DM. Wang Z, et al. J Neurosci. 2017 Dec 6;37(49):11947-11966. doi: 10.1523/JNEUROSCI.2009-17.2017. Epub 2017 Nov 3. J Neurosci. 2017. PMID: 29101243 Free PMC article. - Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
Ye X, Feng T, Tammineni P, Chang Q, Jeong YY, Margolis DJ, Cai H, Kusnecov A, Cai Q. Ye X, et al. J Neurosci. 2017 Mar 8;37(10):2639-2655. doi: 10.1523/JNEUROSCI.2851-16.2017. Epub 2017 Feb 3. J Neurosci. 2017. PMID: 28159908 Free PMC article. - Slow Release of Hydrogen Sulfide in CA1 Hippocampal Neurons Rescues Long-Term Synaptic Plasticity and Associativity in an Amyloid-β Induced Model of Alzheimer's Disease.
Manakkadan A, Krishnan D, Rui Xia Ang S, Sajikumar S. Manakkadan A, et al. J Alzheimers Dis. 2024;101(3):913-921. doi: 10.3233/JAD-240456. J Alzheimers Dis. 2024. PMID: 39302367 - Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.
Nimmrich V, Ebert U. Nimmrich V, et al. Rev Neurosci. 2009;20(1):1-12. doi: 10.1515/revneuro.2009.20.1.1. Rev Neurosci. 2009. PMID: 19526730 Review. - To think or not to think: synaptic activity and Abeta release.
Schroeder BE, Koo EH. Schroeder BE, et al. Neuron. 2005 Dec 22;48(6):873-5. doi: 10.1016/j.neuron.2005.12.005. Neuron. 2005. PMID: 16364890 Review.
Cited by
- Physiological Roles of β-amyloid in Regulating Synaptic Function: Implications for AD Pathophysiology.
Cai W, Li L, Sang S, Pan X, Zhong C. Cai W, et al. Neurosci Bull. 2023 Aug;39(8):1289-1308. doi: 10.1007/s12264-022-00985-9. Epub 2022 Nov 28. Neurosci Bull. 2023. PMID: 36443453 Free PMC article. Review. - Aβ1-16 controls synaptic vesicle pools at excitatory synapses via cholinergic modulation of synapsin phosphorylation.
Anni D, Weiss EM, Guhathakurta D, Akdas YE, Klueva J, Zeitler S, Andres-Alonso M, Huth T, Fejtova A. Anni D, et al. Cell Mol Life Sci. 2021 Jun;78(11):4973-4992. doi: 10.1007/s00018-021-03835-5. Epub 2021 Apr 17. Cell Mol Life Sci. 2021. PMID: 33864480 Free PMC article. - Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging.
Matías-Guiu JA, Oreja-Guevara C, Cabrera-Martín MN, Moreno-Ramos T, Carreras JL, Matías-Guiu J. Matías-Guiu JA, et al. Front Neurol. 2016 Mar 31;7:53. doi: 10.3389/fneur.2016.00053. eCollection 2016. Front Neurol. 2016. PMID: 27065425 Free PMC article. Review. - The Alzheimer's amyloid-degrading peptidase, neprilysin: can we control it?
Nalivaeva NN, Belyaev ND, Zhuravin IA, Turner AJ. Nalivaeva NN, et al. Int J Alzheimers Dis. 2012;2012:383796. doi: 10.1155/2012/383796. Epub 2012 Jul 26. Int J Alzheimers Dis. 2012. PMID: 22900228 Free PMC article. - Time-dependent reversal of synaptic plasticity induced by physiological concentrations of oligomeric Aβ42: an early index of Alzheimer's disease.
Koppensteiner P, Trinchese F, Fà M, Puzzo D, Gulisano W, Yan S, Poussin A, Liu S, Orozco I, Dale E, Teich AF, Palmeri A, Ninan I, Boehm S, Arancio O. Koppensteiner P, et al. Sci Rep. 2016 Sep 1;6:32553. doi: 10.1038/srep32553. Sci Rep. 2016. PMID: 27581852 Free PMC article.
References
- Science. 2001 May 25;292(5521):1550-2 - PubMed
- Annu Rev Physiol. 2002;64:355-405 - PubMed
- Ann Neurol. 1990 May;27(5):457-64 - PubMed
- Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3228-33 - PubMed
- Pharmacol Ther. 2005 Nov;108(2):129-48 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical